Artiva (ARTV) Director Daniel G. Baker Receives 16,250-Share Award

What Happened Daniel G. Baker, a director of Artiva Biotherapeutics (ARTV), received a grant/award of derivative securities covering 16,250 shares on September 10, 2026. The reported price per share is $0.00 (no cash paid at grant); the filing lists this as an award/derivative transaction rather than a purchase or sale.

Key Details

• Transaction date: 2026-09-10; Form 4 filed: 2026-09-14 (timely—filed by the second business day after the transaction).
• Transaction type/code: Award/Grant (Code A), derivative security covering 16,250 shares.
• Price: $0.00 per share reported (no immediate cash paid).
• Vesting: Footnote states the shares subject to the option will vest in full on the earlier of September 10, 2027, or the issuer's 2027 annual stockholder meeting.
• Shares owned after transaction: Not disclosed in the provided filing excerpt.
• Filing status: Timely filed; no late-filing indication in this report.

Context This was a compensation-style grant of a derivative security (an option/award) that vests in the future, not a market buy or sale. Such awards are common for board members and do not necessarily signal a near-term trade—the award only converts into vested shares on the stated vesting date and may have other exercise or transfer conditions not detailed here.